Whole-genome Sequencing Reveals Genetic Signature of Bedaquiline Resistance in a Clinical Isolate of Mycobacterium Tuberculosis
Overview
Affiliations
Objectives: The emergence of multidrug-resistant (MDR) and extensively drug-resistant (XDR) Mycobacterium tuberculosis strains has opened up new challenges for tuberculosis (TB) control in India. This study examined molecular markers of resistance to bedaquiline, a new antituberculous drug with the potential to dramatically improve MDR-TB treatment outcomes and to reduce mortality.
Methods: A clinical M. tuberculosis isolate with a MDR-TB profile was subjected to whole-genome sequencing using an Illumina NextSeq500 platform, followed by genome-wide sequence analysis.
Results: A mutation in the Rv0678 coding region associated with in vitro bedaquiline resistance was identified. The strain represented the Delhi/CAS lineage.
Conclusions: This first report of a potentially bedaquiline-resistant M. tuberculosis strain in India highlights the role of genome-wide sequence analysis of isolates from TB cases with a history of treatment in countries with a high burden of MDR-TB and XDR-TB.
Intra-Host Evolution Among Drug-Resistant Tuberculosis Patients Failing Treatment.
Perumal R, Khan A, Naidoo K, Ngema S, Nandlal L, Padayatchi N Infect Drug Resist. 2023; 16:2849-2859.
PMID: 37193296 PMC: 10182815. DOI: 10.2147/IDR.S408976.
Adewumi A, Soremekun O, Ajadi M, Soliman M RSC Adv. 2022; 10(39):23466-23483.
PMID: 35520325 PMC: 9054810. DOI: 10.1039/d0ra03206a.
Dookie N, Khan A, Padayatchi N, Naidoo K Front Microbiol. 2022; 13:775030.
PMID: 35401475 PMC: 8988194. DOI: 10.3389/fmicb.2022.775030.
Ismail N, Riviere E, Limberis J, Huo S, Metcalfe J, Warren R Lancet Microbe. 2021; 2(11):e604-e616.
PMID: 34796339 PMC: 8597953. DOI: 10.1016/s2666-5247(21)00175-0.
Hulten K, Genta R, Kalfus I, Zhou Y, Zhang H, Graham D Gastroenterology. 2021; 161(5):1433-1442.e2.
PMID: 34293298 PMC: 9047521. DOI: 10.1053/j.gastro.2021.07.012.